insights_auto
Why is AGIO down ၃.၁၀%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၈.၇၆ US$
arrow_downward
-၃.၁၀%(-၀.၉၂) 1D
၂၈.၇၆ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၁၉, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၂၉.၉၃ US$
High
၃၀.၃၅ US$
Low
၂၈.၇၁ US$
Mkt. cap
၁၇၂.၀၁ ဋေ
Avg. vol.
၁.၁၈ သန်း
Volume
၅.၀၀
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၂၉.၉၃ US$
High
၃၀.၃၅ US$
Low
၂၈.၇၁ US$
Mkt. cap
၁၇၂.၀၁ ဋေ
Avg. vol.
၁.၁၈ သန်း
Volume
၅.၀၀
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
marketscreener.com
·
ပြီးခဲ့သည့် ၄၁ မိနစ်
Societe Generale sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Traders Union
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
Mohamed A. El-Erian: S&P 500 may face longest losing streak since 2020 as 10-year Treasury yield falls
24/7 Wall St.
·
ပြီးခဲ့သည့် ၁၃ မိနစ်
The S&P 500 Just Had Its Biggest Reversal Since March 2020
TradingView
·
ပြီးခဲ့သည့် ၃ နာရီ
Stock Market Today: Dow Jones, S&P 500 Futures Fall as Trump Weighs Iran Decision— INTU, ROST, KEYS in Focus
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc